Numerous clinical trials are always active (ie, open and enrolling patients) in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults who have or are at risk of developing cancer. The buttons below depict the general research categories being investigated in ECOG-ACRIN clinical trials. To access information within a particular category, click on the relevant button. Upon clicking, the color of the button will change from grey to red, and a table will appear on screen. The table will display the study number, study description, lead investigator(s), accrual goal, and the date the trial was activated (began enrolling patients). Please read the ECOG-ACRIN Disclaimer in its entirety before accessing this information.
To inquire about a particular trial, send us an email using our contact form. Alternatively, send an email to the study chair; click on their hyperlinked name and a new email window will open. To view educational materials, click on the links provided in the Educational Materials column.
|STUDY||DESCRIPTION||ECOG-ACRIN POS CHAIR|
|DATE ACTIVATED||EDUCATIONAL MATERIALS|
|EAQ152 aka COMET||COMmunication and Education in Tumor Profiling||Angela R. Bradbury, MD||400 for genetic education|
100 for genetic counseling
|E1Q11 aka EROS||EROS: Engendering Reproductive Health Within Oncologic Survivorship||Lynne I. Wagner, PhD|
(Ju-Whei Lee, PhD)
|E1Z11 aka AIMSS||A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor MusculoSkeletal Symptoms (AIMSS)|
***The African American cohort for E1Z11 closed to patient enrollment on July 10, 2015 as it met its accrual goal. Patient enrollment continues for the other cohorts in this trial. ***
|Vared Stearns, MD, Chair|
Victor T. Chang, MD, Co-Chair